Concepedia

Author

Jennifer Kern Sliwa

Janssen (United States)ORCID

Also Known As

J Sliwa, J.K. Sliwa, Jennifer K Sliwa, Jennifer K. Sliwa, Jennifer Kern Sliwa

31

Publications

556

Citations

12

H-Index

9

Concepts

All Affiliations

Janssen (United States)Janssen Scientific Affairs (United States)Johnson & Johnson (United States)Janssen (Belgium)
JK

About

Jennifer Kern Sliwa is an author at Janssen (United States) specializing in schizophrenia, psychopathology, and psychiatry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

50

2

Social Sciences

2

2

50

3

Psychiatry

2

2

50

4

Psychopathology

2

2

50

5

Pharmacology

1

1

29

Jennifer Kern Sliwa

×

11

Publications

265

Citations

11

H-Index

YearCitations

Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial

Larry Alphs, Cynthia A. Bossie, Jennifer Kern Sliwa,

Annals of General Psychiatry

2011

54

Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial

Cynthia A. Bossie, Jennifer Kern Sliwa, Yi-Wen Ma,

BMC Psychiatry

2011

34

Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia

Dong‐Jing Fu, Cynthia A. Bossie, Jennifer Kern Sliwa,

International Clinical Psychopharmacology

2013

29

Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics

Christoph U. Correll, Jennifer Kern Sliwa, Dean Najarian,

CNS Spectrums

2018

23

Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial

Cynthia A. Bossie, Dong‐Jing Fu, Jennifer Kern Sliwa,

Therapeutic Advances in Psychopharmacology

2011

22

Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone

Jennifer Kern Sliwa, Cynthia A. Bossie, Yi-Wen Ma,

Schizophrenia Research

2011

21

Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases

Larry Alphs, Srihari Gopal, Keith Karcher,

Current Drug Safety

2011

20

Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations

Alberto Russu, Jennifer Kern Sliwa, Paulien Ravenstijn,

International Journal of Clinical Practice

2018

20

Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate

Jennifer Kern Sliwa, Dong‐Jing Fu, Cynthia A. Bossie,

BMC Psychiatry

2014

17

An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate

Jennifer Kern Sliwa, Adam Savitz, Isaac Nuamah,

Perspectives In Psychiatric Care

2018

13

Page 1